Dietary Quercetin Augments Activator Protein-1 and Does Not Reduce Nuclear Factor-κB in the Renal Cortex of Rats with Established Chronic Glomerular Disease (original) (raw)
Article navigation
Research Articles| February 25 2002
Department of Renal Medicine, University of Sydney at Westmead Hospital, Westmead, Sydney, Australia
Search for other works by this author on:
Department of Renal Medicine, University of Sydney at Westmead Hospital, Westmead, Sydney, Australia
Search for other works by this author on:
Department of Renal Medicine, University of Sydney at Westmead Hospital, Westmead, Sydney, Australia
Search for other works by this author on:
Nephron (2002) 90 (3): 313–319.
Abstract
Background/Aims: Quercetin, a naturally occurring dietary flavonoid, is a potent in vitro inhibitor of the transcription factors, nuclear factor (NF)-ĸB and activator protein (AP)-1. Here we investigated the efficacy of quercetin to suppress renal cortical NF-ĸB/AP-1 activation and tubulointerstitial injury, in vivo, in a nephrotic rat model of chronic glomerular disease. Methods: Adult male Wistar rats with (n = 27) or without (n = 15) Adriamycin nephropathy (AN) were stratified into six groups (according to proteinuria and endogenous creatinine clearance, measured on day 10) and pair-fed a semipurified diet supplemented with or without quercetin (0.5, 2%) from day 14 to 36. Results: Quercetin-fed rats had minimal weight gain during the study (p < 0.05). In AN, proteinuria, the decline in endogenous creatinine clearance, hypercholesterolaemia and cortical tubulointerstitial injury were not reduced by quercetin. Quercetin had no effect on renal cortical NF-ĸB activation, but unexpectedly exacerbated the induction of AP-1 in AN (by 67%, p < 0.05). In normal rats, quercetin increased proteinuria (by 75%, p < 0.05), renal cortical AP-1 activation (by 198%, p = 0.06), and malondialdehyde production (by 110%, p < 0.05). Conclusion: These data suggest that supplementation of the diet with quercetin is not an effective therapeutic strategy alone to reduce NF-ĸB/ AP-1 activation in chronic glomerular diseases, and paradoxically could be associated with adverse renal effects.
References
Lee JI, Burckart GJ: NF-κB: Important transcription factor and therapeutic target. J Clin Pharmacol 1998;38:981–993.
Foletta VC, Segal DH, Cohen DR: Transcriptional regulation in the immune system: All roads lead to AP-1. J Leukoc Biol 1998;63:139–152.
Rangan GK, Wang Y, Tay YC, Harris DCH: Inhibition of NF-κB activation reduces cortical tubulointerstitial injury in proteinuric rats. Kidney Int 1999;36:118–134.
Rangan GK, Wang Y, Tay YC, Harris DCH: Cytokine gene expression in Adriamycin nephropathy: Effects of antioxidant NF-κB inhibitors in established disease. Nephron 2000;86:482–490.
Takeshita A, Chen Y, Watanabe A, Kitano S, Hanazawa S: TGF-β induces the expression of monocyte chemoattractant protein-1 via transcription factor AP-1 induced by protein kinase in osteoblastic cells. J Immunol 1995;155:419–426.
Middleton E: Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol 1998;439:175–182.
Kitamura M, Ishikawa Y: Oxidant-induced apoptosis of glomerular cells: Intracellular signaling and its intervention by bioflavonoid. Kidney Int 1999;56:1223–1229.
Rangan GK, Wang Y, Tay Y-C, Harris DCH: Inhibition of NF-κB activation is correlated with reduced cytokine transcription in proximal tubular cells. Am J Physiol 1999;277:F779–F789.
Shoskes DA: Effect of bioflavonoids quercetin and curcumin on ischemic renal injury. Transplantation 1998;66:147–152.
Manach C, Morand C, Texier O: Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J Nutr 1995;125:1911–1922.
Morand C, Crespy V, Manach C, Besson C, Demigne C, Remesy C: Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol 1998;275:R212–R219.
Ambrose AM, Robbins DJ, DeEds F: Comparative toxicities of quercetin and quercitrin. J Am Pharm Assoc Sic Ed 1952;41:119–122.
Ueno I, Nakano N, Hirono I: Metabolic fate of [14C] quercetin in the ACI rat. Jpn J Exp Med 1983;53:41–50.
Kahl R: Protective and adverse biological actions of phenolic antioxidants; in Sies H (ed): Oxidative Stress: Oxidants and Antioxidants. New York, Academic Press, 1991, pp 245–273.
Kuhlmann MK, Burkhardt G, Wagner M, Kohler H: Reduction of cisplatin toxicity in cultured renal tubular cells by the bioflavanoid quercetin. Arch Toxicol 1998;72:536–540.
Venkatesan N, Punithavathi D, Arumugam V: Curcumin prevents adriamycin nephrotoxicity in rats. Br J Pharmacol 2000;129:231–234.
Jones EA, Shoskes DA: The effect of mycophenolate mofetil and polyphenolic bioflavonoids on renal ischaemia reperfusion injury and repair. J Urol 2000;163:999–1004.
Morrissey JJ, Klahr S: Enalapril decreases NF-κB activation in the kidney with ureteral obstruction. Kidney Int 1997;52:926–933.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
Sign in
Digital Version
Pay-Per-View Access
$45.00
1 Karger Article Bundle Token
$170
Rental
This article is also available for rental through DeepDyve. 